Navigation Links
Generex Announces Extension of Global Medical Direct Acquisition Closing Date
Date:12/23/2010

ntigenexpress.com/">www.antigenexpress.com.

Safe Harbor Statement

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not.  Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement.  No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.  Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.  Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials.  Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of cl
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- In a sweeping analysis assessing the current state of ... researchers conclude that there remains considerable room for improving ... groups, but especially for adolescents and young adults. The ... underscoring the need to address barriers to care and ... 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
(Date:5/21/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced that on ... company,s vice president of operations, was granted an option to ... per share exercise price of $0.43, the closing trading price ... to Cardica, Inc.,s Inducement Plan, which was approved by the ... of the Nasdaq Global Market for equity grants to induce ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2
... DURECT Corporation,(Nasdaq: DRRX ) announced today ... accepted the New Drug Application (NDA) of REMOXY(R) ... Review to drug,candidates that have the potential to ... goal for completing review of a drug,with Priority ...
... Receive Milestone Payment from MedImmune, PRINCETON, N.J., ... announced today that its partner MedImmune, Inc. has,initiated ... for the,potential treatment of systemic lupus erythematosus (SLE ... by Medarex,s UltiMAb Human,Antibody Development System(R). Under the ...
Cached Medicine Technology:REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 2Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 3Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus 4
(Date:5/22/2015)... According to Berks and Beyond , ... death, totaling almost 2,500 confirmed drug deaths, as reported on ... totals 2,489 deaths stemming from legal and illegal drug use ... people every day to fatal overdoses or other drug related ... one of the most rife with drug related deaths. The ...
(Date:5/22/2015)... RICHMOND, VA (PRWEB) May 22, 2015 sweetFrog ... newest location in Jacksonville, Texas. Jacksonville is now the 16th ... frozen yogurt chain was listed as #22 on the Inc. ... , “I have lived and worked in East Texas for ... said Brad Anderson, owner of the Jacksonville, and nearby Palestine, ...
(Date:5/22/2015)... 2015 Ticket Down is a reputable source ... NHL Eastern Conference Finals Tickets . All seating for ... in the ticket listing. , For the first time ... top of the Eastern Conference. One of the original franchises ... ups and downs over the years, but the excitement level ...
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS have launched ... immediately deliver fully integrated dental implant services to their patients. ... surgeon. , The Center, whose name is ImplantWide, ... placing dental implants. These 6 roadblocks can discourage any ... placement of dental implants into his or her practice. ...
(Date:5/22/2015)... IL (PRWEB) May 22, 2015 In ... Fitness patrons, the section containing particular muscles stretches has ... With nearly 50% of stretches now complete, Chunk Fitness ... are planned to be filmed and released at a ... can be found here: http://www.chunkfitness.com/stretches . , About ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2
... With safety issues making,headlines, pharmaceutical and ... Organizations are relying on their quality function,to ... Proper,staffing of quality roles is just one ... study by pharmaceutical benchmarking leader Best,Practices, LLC ...
... Mass., April 18 LeMaitre,Vascular, Inc. (Nasdaq: LMAT ... quarter financial results on April 30, 2008, after the ... conference call will be hosted,the same day at 5:00 ... internet., Interested participants may listen to the live ...
... study concludes weight gain is an early symptom, not a ... not the obesity it causes, is the actual cause of ... the University of Texas Southwestern Medical Center at Dallas. , ... increase the risk of developing insulin resistance, fatty liver, heart ...
... 18 Dr. James B.,Peake, the Secretary of ... open a unique vocational counseling center for disabled,veterans., ... this center is yet,another partnership that recognizes the ... and access to resources to veterans sets,the stage ...
... CEO and CFO to begin after markets ... close at 2:00 p.m. PT (5:00 p.m. ET), ... inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced it,will release ... the market closes on Tuesday, April 29, 2008., A conference ...
... of South,Carolina today announced that Greenville businesswoman Minor Mickel ... native of Elberton, Ga., Shaw now lives in Greenville, ... family investment corporation.,She previously worked for C & S ... South Carolina, and Manly Investment Group in real estate,development., ...
Cached Medicine News:Health News:Pharma Manufacturing Quality: Optimizing Processes for FDA Compliance 2Health News:Metabolic Syndrome Triggered by Overeating, Not Obesity 2Health News:Disabled Counseling Center Comes to Twin Cities 2Health News:Masimo to Report First Quarter 2008 Financial Results on April 29, 2008 2Health News:Shaw Elected to S.C. BlueCross BlueShield Board 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: